GDF-15 is a potential candidate biomarker for an elevated risk of cardiotoxicity in breast cancer patients receiving neoadjuvant dual anti-HER2 therapy
Article in Frontiers in Pharmacology (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (May 2024)
Article in Environmental Research (August 2023)
Preprint in Research Square (July 2023)